EMBC — Stock Film
STOCK FILMSCENE 1/11EMBC · $3.37
Stock Expert AI presents
EMBC
Embecta Corp
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Embecta Corp. A quick introduction.

On the stock market since 2022, it operates in the world of health and science. It has 1,850 employees. Now — the numbers.

on the stock market since 2022
1,850 employees
$199.9M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $9 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 9%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
80%Safety
Safety 80%Manufacturing Facility 12%Product and Service, Other 8%
80% of all revenue comes from a single line: Safety.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Cash on hand:
$0
Total debt:
$0
The debt outweighs the cash.

The gap is $1.2B. In times of high interest rates, a gap like that can squeeze a company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
94
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
73
strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
80
very strong

The price looks reasonable next to what the company earns.

GROWTH
64
average

There is growth, but not at top-of-the-class tempo.

PRICE MOMENTUM
11
very weak

Clearly below the class average.

WORTH WATCHING

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 5 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking10/10
Few are betting against it10/10
WEAK SPOTS
Growth has stalled2/10
Little set aside for the future2/10
The stock has lost its spark3/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 93% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Executives are buying their own stock

Over the last 12 months, company executives reported 17 buys and 7 sells. Management buying with its own money is usually read as a good sign.

2
THE BRIGHT SIDE · 2/3
Analysts’ target sits above today’s price

The average analyst price target is $5.0048% above today’s price.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $0.46 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 3 years, sales fell about 1% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 11/100. For a turnaround signal, the stock first needs to close the gap with the market.

3
THE RISKS · 3/3
Growth has stalled

The sales tempo runs behind the sector. Council score: 2/10. The high “Growth” grade on the report card comes from profit power instead.

FINALE · THE GRADE
B
0 / 100 · MoonshotScore

On our five-subject report card, EMBC sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: EMBC is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film